A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

Conditions:   Herpes Zoster;   Vaccine-Preventable Diseases Intervention:   Biological: Recombinant Herpes Zoster Vaccine (LZ901) Sponsor:   Beijing Luzhu Biotechnology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials